NEW YORK (GenomeWeb News) – CombiMatrix reported after the close of the market on Wednesday that its first-quarter revenues tumbled 23 percent year over year on weak government contracts and product sales.

CombiMatrix brought in total revenues of $1.5 million for the three-month period ended March 31, compared to total revenues of $2 million in the period a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.